Expressions of interest are invited to join the National Non-Hodgkin Lymphoma Clinical Reference Group (CRG) for the following vacancies:
- Consultant Medical Oncology Representative, England or Wales
- Clinical Nurse Specialist Representative, England or Wales
About NNHLA
NNHLA is a pivotal data-driven initiative that evaluates the quality of care for people with non-Hodgkin lymphoma (NHL) in England and Wales. NNHLA supports NHS Trusts/Local Health Boards, Cancer Alliances, and policymakers to improve outcomes for people diagnosed with non-Hodgkin lymphoma.
One of NNHLA’s standout features is its commitment to quality improvement. The NNHLA Quality Improvement Plan outlines five strategic goals:
- Improving timely diagnosis and treatment
- Treatment appropriate to the subtype of NHL
- Improving safety and reducing toxicity of NHL therapy
- Improving overall survival
- Reducing variation in NHL management among NHS providers.
These objectives are supported by eleven performance indicators, ensuring a structured approach to improving patient outcomes and care.
NNHLA utilises routinely collected NHS data, our recently published NNHLA Quarterly Data Dashboard offers an up-to-date view of the Audit’s key performance indicators. This dashboard, along with our comprehensive State of the Nation Report (September 2025), provides a detailed overview of our current work and findings.
About the Clinical Reference Group role
As a member of the NNHLA Clinical Reference Group, you will have the opportunity to shape the Audit’s approach and delivery. Current membership of the Clinical Reference Group is available to view here.
The Terms of Reference for the Clinical Reference Group are included below.
Members serve for a minimum of one year and the group meets twice a year (via MS Teams).
Eligibility
- Practising in the NHS in England or Wales.
- Possess clinical expertise in NHL and ideally understand clinical data/audit methodology.
- Be able to communicate audit findings to their professional/patient network.
- Declare any conflicts of interest and adhere to relevant ethical principles regarding undue influence.
How to express interest
Expressions of interest (EoIs) should be no more than one side of A4 and include:
- A brief profile of yourself, including your credentials and any other information of relevance for the role.
- Any potential conflicts of interest.
Please send EoIs to [email protected] by midday on Monday 2 March 2026. If you wish to find out more about the role before submitting an EoI please email [email protected] and the team will be happy to respond to questions.
The National Non Hodgkin Lymphoma Audit is commissioned by the Healthcare Quality Improvement Partnership (HQIP) as part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP), and delivered jointly by the Clinical Effectiveness Unit (CEU) at the Royal College of Surgeons of England and the National Cancer Audit Collaborating Centre (NATCAN).
Clinical Reference Group (CRG) Terms of Reference
Purpose of the Clinical Reference Group
The Clinical Reference Group supports the implementation of the audit by representing patients and stakeholder organisations, jointly providing advisory support through the professional oversight of the direction and delivery of the audit. This group will act as a consultative group to the Project Team on clinical issues as well as issues related to methodology and audit implementation.
The stakeholder organisations or specialties involved in the Clinical Reference Group include:
- British Society of Haematology
- Blood Cancer UK
- Lymphoma Action
- NHS England
- NHS Wales / Wales Cancer Network
- Royal College of Radiologists (RCR)
- National Cancer Registration and Analysis Service
- Wales Cancer Network
- HQIP
Terms of Reference
The Clinical Reference Group will:
- Represent the views of patients and the associated professional groups
- Advise on the audit’s scope and aims and help to identify audit questions
- Be consulted and advise on the nature of the audit questions and aims
- Oversee the clinical direction and delivery of the audit
- Act as a consultative group on clinical, methodological and implementation issues, including reflecting on audit design, advising on participation of NHS providers, making recommendations on indicators and metrics, and identifying priority areas for quality improvement
- Provide specialist input or advice to the Project Team on data collection
- Input into the analysis and interpretation of the audit’s findings
- Advise on communication and publication strategies, and appropriateness of audit outputs for different audiences
- Disseminate news of NNHLA progress to members of their stakeholder organisation.
Meetings & Communications
- The Clinical Reference Group will meet every 6 months at the RCSEng, London, with meetings generally being of no more than 2 hours duration. Attendance via Microsoft Teams is also available for the convenience of members.
- The quorum for a Clinical Reference meeting will be the chair and four members (excluding the Project Team), to include at least one Audit clinical lead.
- Meeting papers will be circulated electronically in advance of the meeting.
- If members are unable to attend the meeting, they are asked to send comments on relevant papers for discussion during the meeting or to arrange for a member of their representative body to deputise on their behalf.
- Discussions and also any documentation shared within the Clinical Reference Group are considered confidential unless otherwise indicated.
- Minutes/action points will be circulated electronically after the meeting.
- The RCSEng will reimburse standard class travel expenses.